RPHM · Categories · Form 4

RPHM - SEC Form 4 insider transactions

Reneo Pharmaceuticals Inc. (RPHM) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for RPHM

• 609d
  President and CEO Saccomano Nicholas A was granted 4,556 shares (SEC Form 4)

  4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 609d
  SEC Form 4 filed by Director Phillips Andrew John

  4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 609d
  SEC Form 4 filed by Director Mathers Edward T

  4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 609d
  SEC Form 4 filed by Director Manke Isaac

  4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 609d
  Chief Financial Officer Leverone Jason A. was granted 16,331 shares (SEC Form 4)

  4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 609d
  SEC Form 4 filed by Director Jansen Valerie Malyvanh

  4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 609d
  SEC Form 4 filed by Chief Scientific Officer Hartley Dylan

  4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 609d
  SEC Form 4 filed by Director Grey Michael G

  4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 609d
  Director Carruthers R Michael was granted 4,939 shares (SEC Form 4)

  4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 609d
  SEC Form 4 filed by Chief Medical Officer Agresta Samuel

  4 - OnKure Therapeutics, Inc. (0001637715) (Issuer)
• 1015d
  SEC Form 4: Hall Ashley exercised 15,625 shares at a strike of $1.80 and sold $98,058 worth of shares (15,625 units at $6.28)

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1048d
  SEC Form 4 filed by Grey Michael G

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1082d
  SEC Form 4 filed by Novo Holdings A/S

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1097d
  SEC Form 4 filed by Mathers Edward T

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1097d
  SEC Form 4 filed by Blunt Roshawn A.

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1097d
  SEC Form 4 filed by Grey Michael G

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1097d
  SEC Form 4 filed by Hoelscher Paul W.

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1097d
  SEC Form 4 filed by Muralidhar Bali

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1097d
  SEC Form 4 filed by O'Donnell Niall

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1097d
  SEC Form 4 filed by Seltzer Stacey Denenberg

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1097d
  SEC Form 4 filed by Dube Eric M

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1126d
  SEC Form 4 filed by O'Donnell Niall

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1274d
  SEC Form 4 filed by Lam Jennifer

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1274d
  SEC Form 4 filed by Hall Ashley

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1274d
  SEC Form 4 filed by Flesher Gregory J.

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1274d
  SEC Form 4: Dorenbaum Alejandro gifted 22,348 shares, decreasing direct ownership by 43% to 30,000 units

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1274d
  SEC Form 4 filed by Cruse Michael

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1376d
  SEC Form 4: Cruse Michael bought $25,448 worth of shares (7,500 units at $3.39)

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1376d
  SEC Form 4: Grey Michael G exercised 50,000 shares at a strike of $1.97

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1378d
  SEC Form 4: Cruse Michael bought $23,243 worth of shares (7,255 units at $3.20), increasing direct ownership by 3% to 31,758 units

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1407d
  SEC Form 4 filed by Blunt Roshawn A.

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1467d
  SEC Form 4 filed by Mathers Edward T

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1467d
  SEC Form 4 filed by Grey Michael G

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1467d
  SEC Form 4 filed by Seltzer Stacey Denenberg

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1467d
  SEC Form 4 filed by Dube Eric M

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1467d
  SEC Form 4 filed by Muralidhar Bali

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1467d
  SEC Form 4 filed by Hoelscher Paul W.

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1467d
  SEC Form 4 filed by O'Donnell Niall

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1558d
  SEC Form 4 filed by Cruse Michael

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1597d
  SEC Form 4 filed by Hoelscher Paul W.

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1638d
  SEC Form 4: Jindal Vineet R. was granted 30,000 shares, increasing direct ownership by 455% to 36,600 units

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1638d
  SEC Form 4: Flesher Gregory J. was granted 100,000 shares, increasing direct ownership by 1,042% to 109,600 units

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1638d
  SEC Form 4: Dorenbaum Alejandro was granted 30,000 shares, increasing direct ownership by 134% to 52,348 units

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1638d
  SEC Form 4: Cruse Michael was granted 25,000 shares, increasing direct ownership by 610% to 29,100 units

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1667d
  SEC Form 4: Hall Ashley was granted 30,000 shares

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1748d
  SEC Form 4: Jindal Vineet R. bought $37,176 worth of Common Stock (5,000 units at $7.44)

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1748d
  SEC Form 4: Flesher Gregory J. bought $64,000 worth of Common Stock (8,000 units at $8.00)

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1748d
  SEC Form 4: Cruse Michael bought $18,616 worth of Common Stock (2,500 units at $7.45)

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1790d
  SEC Form 4: Johnson Wendy S. sold $949,756 worth of Common Stock (111,736 units at $8.50), closing all direct ownership in the company

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1790d
  SEC Form 4: Muralidhar Bali bought $949,756 worth of Common Stock (111,736 units at $8.50)

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1796d
  SEC Form 4: Johnson Wendy S. exercised 111,736 units of Common Stock at a strike of $1.97

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1810d
  SEC Form 4: Muralidhar Bali bought $192,245 worth of Common Stock (20,710 units at $9.28)

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1812d
  SEC Form 4: Muralidhar Bali bought $422,414 worth of Common Stock (47,274 units at $8.94)

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1825d
  SEC Form 4 filed by Reneo Pharmaceuticals Inc.

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1828d
  SEC Form 4 filed by Reneo Pharmaceuticals Inc.

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1833d
  SEC Form 4: Muralidhar Bali bought $133 worth of Common Stock (14 units at $9.50)

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1838d
  SEC Form 4 filed by Reneo Pharmaceuticals Inc.

  4 - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)
• 1840d
  SEC Form 4/A filed by Reneo Pharmaceuticals Inc. (Amendment)

  4/A - Reneo Pharmaceuticals, Inc. (0001637715) (Issuer)

Other RPHM categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends